Strong Dupixent, EYLEA HD Sales Power Regeneron Earnings Beat and Premarket Rally Revenue grew 36% and non-GAAP EPS rose 70% on record Dupixent and EYLEA HD sales. Credit: Regeneron/AI Subscribe now Already have an account? Sign in.
